Navigation Links
Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments

Addiction can lead to hospitalization and drug withdrawal

CHICAGO, May 15, 2007 /PRNewswire/ -- A new survey of hundreds of migraine patients and physicians commissioned by the National Headache Foundation and conducted by Harris Interactive shows that 20 percent of migraine patients are currently taking potentially addictive medications that contain barbiturates or opioids and have not been approved by the U.S. Food and Drug Administration for the relief of migraines.

Migraines affect nearly 30 million Americans, according to the National Headache Foundation.

The survey also shows that patients taking prescription medications not approved by the FDA to treat migraines are more likely to experience drug-related side effects than patients taking prescription medications that have been approved by the FDA as migraine treatments.

"It's important for physicians, especially primary care physicians, who most often treat migraine patients, to be aware that medications containing opioids or barbiturates have the potential to produce drug dependence and addictive behavior, especially with regular use," said Richard B. Lipton, M.D., professor and vice chair of neurology at the Albert Einstein College of Medicine in New York City and director of the Montefiore Headache Center. "FDA-approved medications such as triptans are specifically targeted to treat migraine pain and associated symptoms and have a far better safety profile."

The survey of 502 patients and 201 primary care physicians and neurologists conducted earlier this year found that 53 percent of migraine patients take triptans as the primary prescription medication for their condition, but 20 percent take barbiturates or opioids. Another 27 percent take other medications.

Not All Migraine Treatments Are Equal

Triptans stop a migraine attack after the attack begins by stimulating serotonin, which reduces inflammation and
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
2. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
3. NuPathe Reports Positive Phase One Results for NP101 Transdermal Therapy for Acute Migraine
4. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
5. Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms
6. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
7. Addex Reports Positive Results in Phase IIa Clinical Trial With ADX10059 in Migraine
8. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:7/10/2014)... Integrated Silicon Solution, Inc. (Nasdaq: ... IC solutions, today announced that it will host its ... 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) to ... third quarter ended June 30, 2014. To ... 6:50 a.m. Pacific time on July 24, 2014.  The ...
(Date:7/10/2014)... Ariz. , July 10, 2014   Ventana ...  Group, today announced it has entered into an agreement ... which operates as EMD Serono in the ... , to collaborate with Merck KGaA,s biopharmaceutical division on ... for an undisclosed target using Ventana,s proprietary diagnostic assays. ...
(Date:1/15/2014)... MILTON, N.Y. , Jan. 15, 2014 Sono-Tek Corporation ... three months ended November 30, 2013, compared to sales of ... or 20%. Once again, this quarter has also shown growth ... in the first quarter of this fiscal year. Markets that ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4
(Date:7/10/2014)... News) -- Nature, not nurture, may play the bigger ... new study finds. "As is the case in ... abilities in chimpanzees," William Hopkins of the Yerkes National ... release from the journal Current Biology . ... of intelligence in humans, Hopkins, team said. According ...
(Date:7/10/2014)... THURSDAY, July 10, 2014 (HealthDay News) -- Adults with ... physically abused as children or teenagers than people who ... study. Dyslexia, which affects up to 10 ... Researchers found that 35 percent of adults with this ... compared to 7 percent of those without dyslexia. ...
(Date:7/10/2014)... Kristen Fischer HealthDay Reporter ... help ease the hot flashes that often accompany menopause, new ... than 50 percent of menopausal women, said Dr. Taraneh Shirazian, ... at the Icahn School of Medicine at Mount Sinai Hospital ... more than 10 hot flashes a day, and she added ...
(Date:7/10/2014)... Dennis Thompson HealthDay Reporter ... the Twitter wars that break out regularly between outspoken celebrities ... for your own relationship, a new study suggests. High ... couple, even if the couple is in a long-term relationship, ... users. In turn, that friction can lead to cheating ...
(Date:7/10/2014)... response to today,s announcement that the "Mississippi Baby," believed ... been found to have detectable levels of the virus, ... in this setback but remains hopeful that the scientific ... undetectable for more than two years will continue to ... develop a cure. , "Although we had high ...
Breaking Medicine News(10 mins):Health News:Like Humans, Chimps' Smarts May Rely on Genes 2Health News:Researchers See Link Between Dyslexia, Abuse 2Health News:Losing Weight May Ease Hot Flashes, Study Finds 2Health News:Losing Weight May Ease Hot Flashes, Study Finds 3Health News:Are You Tweeting Your Marriage Away? 2Health News:Are You Tweeting Your Marriage Away? 3Health News:Despite setback, 'Mississippi Baby' represents significant breakthrough in effort to end AIDS 2
... August 2-3, CHICAGO, June 30 From ... nurses and related professionals play a critical,role in ... The Dermatology Nurses, Association (DNA) will offer dermatology,professionals ... formats and,the profession,s best networking opportunities during the ...
... Heart,Association has set August for the premier of Circulation: ... titles to be published,under the banner of Circulation: Journal ... by Lippincott Williams & Wilkins, a part of,Wolters Kluwer ... editor of the new journal. Faxon,is director of strategic ...
... included as part of company,s, comprehensive Pressure Ulcer Prevention Program ... ... MUNDELEIN, Ill., June 30 Medline Industries, Inc.,announced today ... pads and stretcher pads aimed at helping,hospitals and long-term care ...
... the development, marketing and sale of proprietary, patent-pending nutraceutical products, including ... is launching a new pet health care division. , ... ... -- The pet health care division is designed to expand ...
... Results of 2008 World Safety Declaration Survey, ... across organizations, extending it beyond the workplace and ... collaboration and sharing are critical,for keeping employees safe, ... World Safety Declaration (WSD)., The survey results ...
... Robbins & Myers, Inc.,(NYSE: RBN ) today reported ... fiscal third quarter ended May 31, 2008, including $0.14 ... the sale of two product lines in March 2006. ... year period to $0.62,primarily due to higher sales, operating ...
Cached Medicine News:Health News:4th Annual Dermatology Nurses' Association Summer Meeting to Arrive in Windy City 2Health News:American Heart Association Announces Fourth New Journal - Circulation: Cardiovascular Interventions to Debut in August 2Health News:American Heart Association Announces Fourth New Journal - Circulation: Cardiovascular Interventions to Debut in August 3Health News:American Heart Association Announces Fourth New Journal - Circulation: Cardiovascular Interventions to Debut in August 4Health News:Medline Announces Advanced Line of Therapeutic Mattresses, Operating Room Table Pads and Stretcher Pads 2Health News:Medline Announces Advanced Line of Therapeutic Mattresses, Operating Room Table Pads and Stretcher Pads 3Health News: University Health Industries Launches Natural Pet Health Care Division 2Health News:Companies Report Success in Driving Safety Culture at Workplaces 2Health News:Companies Report Success in Driving Safety Culture at Workplaces 3Health News:Companies Report Success in Driving Safety Culture at Workplaces 4Health News:Robbins & Myers Reports Record Third Quarter Results 2Health News:Robbins & Myers Reports Record Third Quarter Results 3Health News:Robbins & Myers Reports Record Third Quarter Results 4Health News:Robbins & Myers Reports Record Third Quarter Results 5Health News:Robbins & Myers Reports Record Third Quarter Results 6Health News:Robbins & Myers Reports Record Third Quarter Results 7Health News:Robbins & Myers Reports Record Third Quarter Results 8Health News:Robbins & Myers Reports Record Third Quarter Results 9Health News:Robbins & Myers Reports Record Third Quarter Results 10
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: